{"podcast":{"title":"Global News Today | 2 Min News | The Daily News Now!","slug":"global-news-today-2-min-news-the-daily-news-now-7448525","podcast_index_feed_id":7448525,"rss_url":"https://feeds.fastcast.ai/global-news-daily-news-now.xml","website_url":"https://thednn.ai/","image_url":"https://image.fastcast.ai/podcasts/global-news-daily-news-now.jpg","author":"The Daily News Now!","episode_count":212,"summary":"Hosted by Corey with the Story, Global News Today delivers fast, focused daily updates on the stories shaping the world—from international politics and business to culture, technology, and global events. Designed for quick, on-the-go listening, each episode brings you up to speed in minutes. Produced by AI for speed, consistency, and global scale, the show is part of The Daily News Now network—the first global local news network bringing updates from every city and region and keeping the world connected. Global News Today is your daily snapshot of what’s happening around the world. Advertise on DNN: advertise@thednn.ai","last_synced_at":"2026-06-16T12:18:48.313730+00:00","page_url":"https://stenobird.com/podcast/global-news-today-2-min-news-the-daily-news-now-7448525"},"episode":{"title":"Breakthrough Pill Extends Pancreatic Cancer Survival","slug":"breakthrough-pill-extends-pancreatic-cancer-survival","published_at":"2026-05-31T13:10:57+00:00","page_url":"https://stenobird.com/podcast/global-news-today-2-min-news-the-daily-news-now-7448525/breakthrough-pill-extends-pancreatic-cancer-survival","show_page_url":"https://stenobird.com/podcast/global-news-today-2-min-news-the-daily-news-now-7448525","url":"https://api.fastcast.ai/audio/d7a3ac36-91d0-497d-84bf-0acce2e50a87.mp3","audio_url":"https://api.fastcast.ai/audio/d7a3ac36-91d0-497d-84bf-0acce2e50a87.mp3","summary":"A breakthrough pill called daraxonrasib is giving advanced pancreatic cancer patients a fighting chance—doubling survival time and improving quality of life in a landmark study. Targeting a previously unreachable mutated protein, this drug outperformed chemotherapy, with patients living 13.2 months versus 6.7 months. Doctors were moved by the results, and regulators are fast-tracking approval. It could even open doors for earlier use and surgery eligibility—offering hope where there was once little. Support the show: Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN: advertise@thednn.ai This is an automated, high-level news summary based on public reporting. Report issues to feedback@thednn.ai. View sources & latest updates: https://sources.thednn.ai/198be4f07606378c","meta_description":"A breakthrough pill called daraxonrasib is giving advanced pancreatic cancer patients a fighting chance—doubling survival time and improving quality of li…","key_points":[],"chapters":[],"topics":[],"duration_seconds":117,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/global-news-today-2-min-news-the-daily-news-now-7448525/episodes/breakthrough-pill-extends-pancreatic-cancer-survival/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/global-news-today-2-min-news-the-daily-news-now-7448525/breakthrough-pill-extends-pancreatic-cancer-survival.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}